EUVIMEDScopri EUVIMED
Übersichtsarbeit

Resinous traditional Chinese medicine for cancer treatment: Mechanisms and therapeutic potential

Ruoxin Zhang iD, Fei Wang iD, Xuejiao Wei iD, Huiming Huang iD, Xinyu Qiu iD, Zhuguo Wang iD, Yufeng Gao iD, Wanying Xie iD, Xiaoxue Wang iD, Changhai Qu iD, Zhongdong Hu iD

British Journal of Pharmacology · 2026-08-23

DOI: 10.1111/bph.70591 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2026-08-23. Written by Ruoxin Zhang and 10 co-authors. Institution: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. 157 references. Funded by: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Talent Cultivation Project of Beijing University of Chinese Medicine.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Resinous traditional Chinese medicines are a ‘treasure trove of natural bioactive molecules’. Their unique hydrophobic components are an important source of antitumour agents. Resinous traditional Chinese medicines, including frankincense, myrrh, gamboge, Sanguis Draconis , Resina Draconis and asafoetida, strongly inhibit the progression of various malignant tumours, such as lung cancer, breast cancer, colorectal cancer, prostate cancer and gastric cancer, through multiple mechanisms. The core antitumour mechanisms are primarily mediated by bioactive constituents, such as resin glycosides, terpenoids and flavonoids, which induce the death of tumour cells, arrest the cell cycle, suppress metastasis, modulate immune responses and inhibit angiogenesis. These active compounds have dual therapeutic value. They not only exert antitumour effects independently but also reverse multidrug resistance. In this review, we systematically summarise the antitumour active components of resinous traditional Chinese medicines and their underlying molecular mechanisms and discuss the current limitations and strategies for their clinical application, to provide novel insights for developing novel antitumour drugs.

Subjects

Author keywords

bioactive componentscancermechanism of actionresearch and development of novel antitumor drugsresinous traditional Chinese medicines

Authors and institutions

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

ORCID profiles: Ruoxin Zhang, Fei Wang, Xuejiao Wei, Huiming Huang, Xinyu Qiu, Zhuguo Wang, Yufeng Gao, Wanying Xie, Xiaoxue Wang, Changhai Qu, Zhongdong Hu

Funding

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Talent Cultivation Project of Beijing University of Chinese Medicine

Cite

APA

Zhang, R., Wang, F., Wei, X., Huang, H., Qiu, X., Wang, Z., Gao, Y., Xie, W., Wang, X., Qu, C., & Hu, Z. (2026). Resinous traditional Chinese medicine for cancer treatment: Mechanisms and therapeutic potential. British Journal of Pharmacology. https://doi.org/10.1111/bph.70591

Vancouver

Zhang R, Wang F, Wei X, Huang H, Qiu X, Wang Z, et al. Resinous traditional Chinese medicine for cancer treatment: Mechanisms and therapeutic potential. British Journal of Pharmacology. 2026. doi:10.1111/bph.70591

BibTeX
@article{Zhang2026,
  author = {Zhang, Ruoxin and Wang, Fei and Wei, Xuejiao and Huang, Huiming and Qiu, Xinyu and Wang, Zhuguo and Gao, Yufeng and Xie, Wanying and Wang, Xiaoxue and Qu, Changhai and Hu, Zhongdong},
  title = {Resinous traditional Chinese medicine for cancer treatment: Mechanisms and therapeutic potential},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70591}
}
Start for free →